Insmed

Connecticut Disclosure

Information for Connecticut prescribers of prescription drugs provided pursuant to Connecticut House Bill 6669.

This information is intended for Connecticut prescribers.

HB 6669

ARIKAYCE® (amikacin liposome inhalation suspension)

Last update: January 2026

Form

BRINSUPRI® (brensocatib) tablets

Last update: August 2025

Form

House Bill 6669. Published by the Connecticut General Assembly.

Please see full Prescribing Information for ARIKAYCE.

Please see full Prescribing Information for BRINSUPRI.

PP-INS-US-00104